Clinical Trials on Fusobacterium Infections in United Kingdom

Total 20151 results

Oxford University Hospitals NHS Trust

Completed

Oral Versus Intravenous Antibiotics for Bone and Joint Infections (OVIVA B&J) (OVIVA)

Bone Infection | Joint Infection

United Kingdom
AiCuris Anti-infective Cures AG

Completed

Thorough QT/QTc of Pritelivir in Healthy Subjects

HSV Infection

United Kingdom
Portsmouth Hospitals NHS Trust
University of Portsmouth

Completed

Biofilm Composition as a Predictive Biomarker for Prosthetic Joint Infection (Biofilms)

Joint Infection

United Kingdom
Enanta Pharmaceuticals, Inc
hVIVO Services Limited

Recruiting

A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model

RSV Infection

United Kingdom
Enanta Pharmaceuticals, Inc
hVIVO Services Limited

Completed

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model

RSV Infection

United Kingdom
Hvivo
GlaxoSmithKline

Completed

RSV Study in Adults 60 to 75 Years of Age

RSV Infection

United Kingdom
Imperial College London

Recruiting

The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus (INFLAMMAGE)

RSV Infection

United Kingdom
Bavarian Nordic

Completed

Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults

RSV Infection

United Kingdom
Meissa Vaccines, Inc.
Hvivo

Completed

Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine

RSV Infection

United Kingdom
Alios Biopharma Inc.

Completed

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Respiratory Syncytial Virus Infections

United Kingdom
Thirty Respiratory Limited

Withdrawn

PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) (PREVENT)

Respiratory Tract Diseases | COVID-19 Respiratory Infection | Respiratory Viral Infection

United Kingdom
Pfizer

Completed

A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Infections

United Kingdom
Janssen Sciences Ireland UC

Completed

Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.

Respiratory Syncytial Virus Infections

United Kingdom
Imperial College London
Sense Biodetection Limited

Unknown

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens (SIMPLIFI)

Enterovirus Infections | Respiratory Syncytial Virus Infections | Human Influenza | Rhinoviral Infections | Metapneumovirus Infection | Parainfluenzae Viral Infections

United Kingdom
Nottingham University Hospitals NHS Trust

Terminated

Ursodeoxycholic Acid in C. Difficile Infection

Clostridioides Difficile Infection

United Kingdom
Barts & The London NHS Trust

Unknown

Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection

Clostridium Difficile Infection

United Kingdom
Royal Marsden NHS Foundation Trust
St George's, University of London; Mologic Ltd; The Royal Marsden Cancer Charity and other collaborators

Completed

Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19) (CARDS)

Coronavirus Infection | Cancer | Infectious Disease

United Kingdom
St George's, University of London

Completed

Understanding COVID-19 Infection in Pregnant Women and Their Babies (periCOVID)

Pregnancy Related | Corona Virus Infection | Breastfeeding | Neonatal Infection

United Kingdom
Chelsea and Westminster NHS Foundation Trust

Unknown

Evaluating Clinical Parameters of COVID-19 in Pregnancy (COpregVID)

COVID-19 | COVID-19 Infection | 2019 Novel Coronavirus Infection

United Kingdom
Imperial College London

Terminated

Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) (PREDICT-ILI)

RNA Virus Infections | Respiratory Tract Infections | Covid19 | Influenza | Infection, Bacterial | SARS (Severe Acute Respiratory Syndrome) | Respiratory Viral Infection | Infection Viral

United Kingdom
Pfizer

Completed

To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)

Bacterial Infections | Complicated Infection

United Kingdom
University of Oxford

Active, not recruiting

RESCEU: Defining the Burden of RSV Disease

Respiratory Syncytial Virus Infections | RSV Infection

United Kingdom
Imperial College London
Wellcome Trust

Completed

The Development of a Human Model of Respiratory Syncytial Virus Infection

Respiratory Syncytial Virus Infections | Respiratory Viral Infections

United Kingdom
University of Oxford

Completed

The Microbiology of Pleural Infection (TORPIDS)

Pleural Infection | Pleural Infection Bacterial

United Kingdom
University College, London
Public Health England

Completed

COG-UK Project Hospital-Onset COVID-19 Infections Study (COG-UK HOCI)

Coronavirus Infection | Covid-19 | SARS-CoV 2 | Coronavirus | Nosocomial Infection

United Kingdom
St George's, University of London
Antibiotic Research UK

Recruiting

Neonatal Antimicrobial Resistance and Outcome (neoAMRO)

Neonatal Infection

United Kingdom
Chelsea and Westminster NHS Foundation Trust

Recruiting

PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs (PHENOTYPE)

COVID-19 | Corona Virus Infection | Coronavirus | 2019 Novel Coronavirus Infection | 2019nCoV

United Kingdom
Liverpool School of Tropical Medicine
University of Oxford

Recruiting

Using BCG Vaccine to Understand Tuberculosis Infection (Pilot BCG CHIM)

Tuberculosis

United Kingdom
Destiny Pharma Plc

Completed

Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

Staphylococcal Infection

United Kingdom
MedImmune LLC

Terminated

Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)

RSV Infection

United Kingdom
University of Derby
University of Exeter; University Hospitals of Derby and Burton NHS Foundation... and other collaborators

Not yet recruiting

An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID. (ERASE-LC)

COVID-19 | SARS-CoV-2 Infection

United Kingdom
Scynexis, Inc.
Inncelerex

Completed

ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects

Fungal Infection

United Kingdom
St George's, University of London
University of Nottingham; Medical Research Council; Public Health England

Recruiting

Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease (iGBS3)

Streptococcus Agalactiae Infection

United Kingdom
Destiny Pharma Plc

Completed

Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects

Staphylococcus Aureus Infection

United Kingdom
Nitric BioTherapeutics, Inc

Terminated

Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

Skin Ulcers | Methicillin-resistant Staphylococcus Aureus Infection

United Kingdom
Janssen Vaccines & Prevention B.V.

Completed

An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults

Healthy

United Kingdom
University of Edinburgh
Medical Research Council; ISLACARE LTD (12108076)

Recruiting

ImplementatioN of Remote Surgical wOund Assessment During the coviD-19 pandEmic (INROADE)

Surgical Site Infection

United Kingdom
Imperial College London
Royal Free Hospital NHS Foundation Trust; Hvivo

Completed

SARS-CoV-2 Human Challenge Characterisation Study

COVID-19 | Covid19 | Corona Virus Infection | SARS-CoV Infection | Coronavirus

United Kingdom
BioCryst Pharmaceuticals
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430

Ebola Virus Infection | Filovirus Infections

United Kingdom
University of Leeds
GlaxoSmithKline; AstraZeneca; Sanofi Pasteur, a Sanofi Company; BioMérieux; Da Volterra and other collaborators

Completed

COMBACTE-CDI Understanding the Burden of C. Difficile Infection (COMBACTE-CDI)

Clostridium Difficile Infection

United Kingdom
Cell Medica Ltd
Technology Strategy Board, United Kingdom

Completed

Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT (ASPIRE)

ADV Infection Post Allo-HSCT

United Kingdom
Imperial College London

Recruiting

Addition of Probenecid to Penicillin-V Therapy (ADDPROPEN)

Infection, Bacterial

United Kingdom
St George's, University of London

Unknown

Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections (TIKA_TB)

Tuberculosis (TB)

United Kingdom
University College, London
Public Health England

Completed

Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection (NextGen)

Tuberculosis

United Kingdom
Queen Mary University of London
University College, London; Public Health England

Completed

Completion and Acceptability of Treatment Across Primary Care and the commUnity for Latent Tuberculosis (CATAPULT)

Latent Tuberculosis

United Kingdom
University of Oxford

Completed

Understanding How Salmonella Typhi Infects Humans (Bottlenecks)

Salmonella Typhi Infection

United Kingdom
Imperial College London
University of Nottingham; University College, London; University of Sheffield; Medical... and other collaborators

Recruiting

The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID. (UKILD)

Interstitial Lung Disease | SARS-CoV-2 Infection

United Kingdom
Imperial College London

Completed

Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection

Liver Fibrosis

United Kingdom
University of Oxford

Terminated

STerOids in COVID-19 Study (STOIC)

Coronavirus Infection

United Kingdom
Ancon Technologies Ltd

Completed

Covid-19 Breath Test

Covid-19 Infection

United Kingdom

Clinical Trials on Fusobacterium Infections in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations